NeuroDex Overview

  • Founded
  • 2018

Founded
  • Status
  • Private

  • Employees
  • 7

Employees
  • Latest Deal Type
  • Seed

  • Investors
  • 3

NeuroDex General Information

Description

Developer of exosome platform intended to provide noninvasive, inexpensive, and robust neurological diagnostic tools. The company's platform offers neuron-derived exosome isolation technology, which provides early detection, patient stratification, and disease monitoring services for neurodegenerative disorders such as Alzheimer's disease, enabling their clients to get effective and preventative treatment for Alzheimer's.

Contact Information

Website
www.neurodex.co
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
  • 27 Strathmore Road
  • Natick, MA
  • United States

NeuroDex Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroDex Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 03-Apr-2020 00000 Completed Generating Revenue
1. Early Stage VC (Series 1) 31-Jan-2020 00000 00000 000 Completed Generating Revenue
To view NeuroDex’s complete valuation and funding history, request access »

NeuroDex Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 000,000 00.000000 00.00 00.00 00 00.00 00.000
To view NeuroDex’s complete cap table history, request access »

NeuroDex Executive Team (3)

Name Title Board Seat Contact Info
Oded Biran Co-Founder, Chief Executive Officer, President & Board Member
Erez Eitan Co-Founder, Chief Scientific Officer & Board Member
Christina Mendonca Controller
To view NeuroDex’s complete executive team members history, request access »

NeuroDex Board Members (3)

Name Representing Role Since
Erez Eitan NeuroDex Co-Founder, Chief Scientific Officer & Board Member 000 0000
Oded Biran NeuroDex Co-Founder, Chief Executive Officer, President & Board Member 000 0000
Raphael Nir NeuroDex Board Member 000 0000
To view NeuroDex’s complete board members history, request access »

NeuroDex Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NeuroDex Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ICV Group Impact Investing Minority 000 0000 000000 0
Formation Venture Engineering Venture Capital Minority 000 0000 000000 0
Intellect Capital Ventures Venture Capital Minority 000 0000 000000 0
To view NeuroDex’s complete investors history, request access »